SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-23-028668
Filing Date
2023-08-14
Accepted
2023-08-14 17:24:06
Documents
23

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 4525962
2 forms-1_001.jpg GRAPHIC 15096
3 forms-1_002.jpg GRAPHIC 10610
4 forms-1_003.jpg GRAPHIC 24957
5 forms-1_004.jpg GRAPHIC 165137
6 forms-1_005.jpg GRAPHIC 13319
7 forms-1_006.jpg GRAPHIC 1474
8 forms-1_007.jpg GRAPHIC 8308
9 forms-1_008.jpg GRAPHIC 1071
10 forms-1_019.jpg GRAPHIC 363
11 forms-1_009.jpg GRAPHIC 1115
12 forms-1_020.jpg GRAPHIC 661
13 forms-1_010.jpg GRAPHIC 1099
14 forms-1_011.jpg GRAPHIC 1055
15 forms-1_021.jpg GRAPHIC 658
16 forms-1_012.jpg GRAPHIC 1064
17 forms-1_022.jpg GRAPHIC 658
18 forms-1_013.jpg GRAPHIC 4855
19 forms-1_014.jpg GRAPHIC 4037
20 forms-1_015.jpg GRAPHIC 4158
21 forms-1_016.jpg GRAPHIC 3909
22 forms-1_017.jpg GRAPHIC 4336
23 forms-1_018.jpg GRAPHIC 4800
  Complete submission text file 0001493152-23-028668.txt   4905387
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267591 | Film No.: 231172119
SIC: 2834 Pharmaceutical Preparations